Joseph C Galante - Net Worth and Insider Trading

Joseph C Galante Net Worth

The estimated net worth of Joseph C Galante is at least $422,107 dollars as of 2024-04-27. Joseph C Galante is the Director of Pinnacle Financial Partners Inc and owns about 4,000 shares of Pinnacle Financial Partners Inc (PNFP) stock worth over $321,160. Joseph C Galante is also the Director of Cumberland Pharmaceuticals Inc and owns about 57,356 shares of Cumberland Pharmaceuticals Inc (CPIX) stock worth over $100,947. Details can be seen in Joseph C Galante's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph C Galante has not made any transactions after 2023-01-20 and currently still holds the listed stock(s).

Transaction Summary of Joseph C Galante

To

Joseph C Galante Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph C Galante owns 3 companies in total, including Cumberland Pharmaceuticals Inc (CPIX) , Pinnacle Financial Partners Inc (PNFP) , and Avenue Financial Holdings Inc (AVNU) .

Click here to see the complete history of Joseph C Galante’s form 4 insider trades.

Insider Ownership Summary of Joseph C Galante

Ticker Comapny Transaction Date Type of Owner
CPIX Cumberland Pharmaceuticals Inc 2022-12-21 director
PNFP Pinnacle Financial Partners Inc 2023-01-20 director
AVNU Avenue Financial Holdings Inc 2016-07-01 director

Joseph C Galante Latest Holdings Summary

Joseph C Galante currently owns a total of 2 stocks. Among these stocks, Joseph C Galante owns 4,000 shares of Pinnacle Financial Partners Inc (PNFP) as of January 20, 2023, with a value of $321,160 and a weighting of 76.09%. Joseph C Galante also owns 57,356 shares of Cumberland Pharmaceuticals Inc (CPIX) as of December 21, 2022, with a value of $100,947 and a weighting of 23.91%.

Latest Holdings of Joseph C Galante

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PNFP Pinnacle Financial Partners Inc 2023-01-20 4,000 80.29 321,160
CPIX Cumberland Pharmaceuticals Inc 2022-12-21 57,356 1.76 100,947

Holding Weightings of Joseph C Galante


Joseph C Galante Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph C Galante has made a total of 4 transactions in Pinnacle Financial Partners Inc (PNFP) over the past 5 years, including 3 buys and 1 sells. The most-recent trade in Pinnacle Financial Partners Inc is the acquisition of 1,000 shares on January 20, 2023, which cost Joseph C Galante around $72,260.

According to the SEC Form 4 filings, Joseph C Galante has made a total of 19 transactions in Cumberland Pharmaceuticals Inc (CPIX) over the past 5 years, including 19 buys and 0 sells. The most-recent trade in Cumberland Pharmaceuticals Inc is the acquisition of 1,550 shares on December 21, 2022, which cost Joseph C Galante around $3,441.

Insider Trading History of Joseph C Galante

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph C Galante Trading Performance

GuruFocus tracks the stock performance after each of Joseph C Galante's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph C Galante is 3.36%. GuruFocus also compares Joseph C Galante's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph C Galante within 3 months outperforms 11 times out of 25 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joseph C Galante's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joseph C Galante

Average Return

-11%

Average return per transaction

Outperforming Transactions

23%

6 out of 26 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.32 3.36 -5.58 -11 -12.58 -15.7
Relative Return to S&P 500(%) 0.43 0.64 -9.73 -20.18 -23.28 -25.62

Joseph C Galante Ownership Network

Ownership Network List of Joseph C Galante

No Data

Ownership Network Relation of Joseph C Galante


Joseph C Galante Owned Company Details

What does Cumberland Pharmaceuticals Inc do?

Who are the key executives at Cumberland Pharmaceuticals Inc?

Joseph C Galante is the director of Cumberland Pharmaceuticals Inc. Other key executives at Cumberland Pharmaceuticals Inc include Vice Pres Sales & Marketing Chris T. Bitterman , Vice Pres Organizational Dev Todd M. Anthony , and director & 10 percent owner & Chairman and CEO A J Kazimi .

Cumberland Pharmaceuticals Inc (CPIX) Insider Trades Summary

Over the past 18 months, Joseph C Galante made 3 insider transaction in Cumberland Pharmaceuticals Inc (CPIX) with a net purchase of 4,540. Other recent insider transactions involving Cumberland Pharmaceuticals Inc (CPIX) include a net purchase of 7,880 shares made by Kenneth Krogulski , a net purchase of 2,093 shares made by James Jones , and a net purchase of 1,299 shares made by Caroline Young .

In summary, during the past 3 months, insiders sold 0 shares of Cumberland Pharmaceuticals Inc (CPIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cumberland Pharmaceuticals Inc (CPIX) were sold and 15,812 shares were bought by its insiders, resulting in a net purchase of 15,812 shares.

Cumberland Pharmaceuticals Inc (CPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cumberland Pharmaceuticals Inc Insider Transactions

No Available Data

Joseph C Galante Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph C Galante. You might contact Joseph C Galante via mailing address: 111 Tenth Avenue, Suite 200, Nashville Tn 37203.

Discussions on Joseph C Galante

No discussions yet.